May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Eric K. Singhi: Does MARIPOSA study update simplify first-line treatment decisions?
Jan 9, 2025, 04:05

Eric K. Singhi: Does MARIPOSA study update simplify first-line treatment decisions?

Eric K. Singhi, Assistant Professor in the Department of General Oncology at The University of Texas MD Anderson Cancer Center, posted on X:

MARIPOSA study update: Combination therapy shows over ONE-YEAR mOS improvement compared to osimertinib alone.

Key data to discuss with patients in clinic—but does this simplify first-line treatment decisions?”

Eric K. Singhi

Dr. Eric K. Singhi is a thoracic and head and neck medical oncologist, currently serving as an Assistant Professor in the Department of General Oncology within the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston, TX.